NCT05744245

Brief Summary

About 50% of people who have a stroke experience difficulty swallowing. There is a growing evidence base showing that swallowing therapy can help to improve swallowing, but we don't know which type or how much therapy is most beneficial. The investigators are further developing one particular intervention - swallow strength and skill training with biofeedback. This involves practicing strong or effortful swallows and practicing controlling the timing of swallowing using visual feedback on a screen showing the activity of the muscles involved in swallowing. The investigators want to know whether trained clinicians are able to deliver this therapy in acute hospital settings early after stroke. The investigators also want to explore whether there is an effect of dose in improving swallowing and other health factors. To do this the investigators will conduct a trial across several stroke units in the east midlands. The study aims to recruit 120 participants who have had a stroke and have dysphagia and who will randomly be placed in one of three groups. One group will get a standard dose therapy (10 x 35 minute sessions over 2 weeks), another group with receive a high dose therapy (20 x 35 minute sessions over 2 weeks) and the third will receive 'usual care' which is what they would usually get from their current service. The investigators will look at what therapy participants actually get, what factors might influence this and the training, support and conditions that enable clinicians to deliver the therapy. The investigators will also assess the participants swallowing and collect information on their health, face to face at the beginning and after the therapy and over the phone at three months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 24, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

May 15, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

March 24, 2025

Status Verified

June 1, 2024

Enrollment Period

1.6 years

First QC Date

December 20, 2022

Last Update Submit

March 19, 2025

Conditions

Keywords

BiofeedbackRehabilitationSurface Electromyography

Outcome Measures

Primary Outcomes (3)

  • Feasibility in patients with acute post stroke dysphagia

    Number of participants recruited, dose of swallow therapy

    Throughout study completion, to be completed by December 2024

  • Feasibility of delivery by acute stroke NHS clinicians - the intervetion

    Percentage of core components of the intervention delivered (fidelity checklist from observations)

    Through study completion, to be completed by December 2024

  • Feasibility of delivery by acute stroke NHS clinicians - the training

    Usefulness of training and training materials (qualitative interviews)

    Through study completion, to be completed by December 2024

Secondary Outcomes (5)

  • Dysphagia Severity

    Day 15

  • Feeding Status

    Day 15

  • Swallow Strength and Skill

    Day 15

  • Pnuemonia

    Day 90

  • Feasibility of cost effectiveness methods

    Day 90

Other Outcomes (1)

  • Swallow safety and efficiency (subsection of participants)

    Day 15

Study Arms (3)

Standard dose

EXPERIMENTAL

1 x 35 minute therapy session of Swallow Strength and Skill training per day, 5 days a week for 2 weeks. 10 sessions in total. Plus usual care

Other: Swallow Strength and Skill Training

High dose

EXPERIMENTAL

2 x 35 minute therapy therapy sessions of Swallow Strength and Skill training, per day, 5 days a week for 2 weeks. 20 sessions in total. Plus usual care

Other: Swallow Strength and Skill Training

Usual care

NO INTERVENTION

Usual care

Interventions

Practice swallowing exercises with biofeedback and strength and skill targets

High doseStandard dose

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults over 18
  • Clinical diagnosis of stroke
  • \>1 week and \< 8 weeks post stroke
  • New moderate to severe dysphagia (DSRS ≥4) with a score of at least 1 on the fluid sub-section
  • Not rapidly improving dysphagia (2 clinical SLT assessments over a week showing minimal change in DSRS)
  • Pass an eligibility screen - sufficient visual, cognitive and communication skills to participate in the intervention

You may not qualify if:

  • Medically unwell, GCS \<10, on \>4L oxygen, poor prognosis, EOLC
  • Previous dysphagia
  • Degenerative neurological condition
  • Severe visual impairment
  • Severe cognitive \& communication impairment
  • Patient likely to be repatriated to or rehabilitated at another organisation with 10 days
  • Participation in another trial aimed at improving dysphagia
  • Unwilling to remove beard/hair from under chin

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Derby

Derby, United Kingdom

Location

MeSH Terms

Conditions

Deglutition DisordersStroke

Condition Hierarchy (Ancestors)

Esophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Jacqueline Benfield, PhD

    University of Nottingham

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2022

First Posted

February 24, 2023

Study Start

May 15, 2023

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

March 24, 2025

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations